Xconomy National

Archives

by in

Entry	Author	Date	Location
Biogen Strikes Deal with Knopp for ALS Drugs, Selecta Gets New CEO, Avantra Scores $7M, & More Boston-Area Life Sciences News	Erin Kutz	08/20/10	Boston
Life Wants Ion Torrent for Fast Gene Sequencing, Biogen-Idec Takes On Lou Gehrig’s Disease, Two Biotechs Move Toward IPOs, & More San Diego Life Science News	Bruce V. Bigelow	08/19/10	San Diego
Biogen Idec Strikes Potential $345M Deal with Knopp to Develop ALS Drug	Ryan McBride	08/18/10	Boston
Cytokinetics, Defying the Fashion in Biotech, Sticks with Gradual Science-Based Strategy	Luke Timmerman	08/04/10	San Francisco
San Diego Inventor’s Drug Discovery is Nothing to Laugh (or Cry) About	Denise Gellene	09/04/09	San Diego
Avanir’s Results for Neurological Drug Triggers Outburst in Trading	Bruce V. Bigelow	08/11/09	San Diego
Isis Prepares Novel Treatment for Lou Gehrig’s Disease, BrainCells Is Encouraged by New Drug for Depression, Inovio Raises $30M, & More San Diego Life Sciences News	Bruce V. Bigelow	08/06/09	San Diego
Targeted Genetics, Mainstay of Gene Therapy, Faces Likely Shutdown	Luke Timmerman	05/07/09	Seattle
State Stem Cell Grants Awarded to Four San Diego Biotechs	Bruce V. Bigelow	12/11/08	San Diego
Ceregene Drug Fails in Parkinson’s Trial	Luke Timmerman	12/01/08	San Diego
Targeted Genetics Cash Will Stretch into First Quarter	Luke Timmerman	11/05/08	Seattle
RXi Takes a Untraditional Route to the Public Market, Now Working To Get Pharma to Pay The Bills	Luke Timmerman	07/18/08	Boston
Targeted Genetics Gets Recommended for up to $2.4 Million Government Grant	Luke Timmerman	07/10/08	Seattle
Page 1 of 1